Hannah Phillips
Psychiatric/Mental Health · Maitland, FLNPI 1881035178
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $349,244 of the $455,401 with a category attached, or 76.7%. Johnson & Johnson accounts for 96.7% of it on its own, with 12 other manufacturers making up the rest. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 513 payments — averaging $887.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$440K
- E.r. Squibb & Sons, L.L.C.$12K
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$181
- Corium, LLC$122
- Acadia Pharmaceuticals Inc$112
- plus $341 from 7 others
What the payments were for
- Consulting fees$16,4504%
- Speaking & faculty fees$349,24477%
- Travel & lodging$78,62617%
- Food & beverage$11,0812%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 463 | $440,402 |
| E.r. Squibb & Sons, L.L.C. | 32 | $12,234 |
| Otsuka America Pharmaceutical, Inc. | 5 | $2,010 |
| AbbVie | 4 | $181 |
| Corium, LLC | 1 | $122 |
| Acadia Pharmaceuticals Inc | 1 | $112 |
| Alkermes, Inc. | 1 | $104 |
| Axsome Therapeutics, Inc. | 1 | $102 |
| Biogen | 1 | $40 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $12 |
| Janssen Scientific Affairs, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$314,485
- INVEGA TRINZA$311,053
- SPRAVATO$120,982
- COBENFY$4,638
- INVEGA$2,002
- ABILIFY MAINTENA$1,971
- ARISTADA$417
- VRAYLAR$125
- Azstarys$122
- NUPLAZID$112
- LYBALVI$104
- Auvelity$102
How this compares
$455,401 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 36 | $44,962 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $440,402 | $44,96236 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Maitland
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
- Carolann BrooksCelebration$57K
- Linda SkalskyGainesville$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.